Karolyn Lui
Regional Director
Health Products and Food Branch
source: CPA related link: www.healthcanada.gc.ca/medeffect The Canadian Adverse Drug Reaction Monitoring Program (CADRMP), announces the relocation of the Regional Adverse Reaction (AR) Centres in British Columbia, Saskatchewan, Ontario, Québec and Atlantic Canada, to Health Canada, Health Products and Food Branch Regional Offices, effective April 01, 2006. The Alberta and Manitoba Regional AR Centres which opened in April 2005 will remain in their present locations. In conjunction with the relocation, the regional AR centres will be referred to as regional AR monitoring offices and will be aligned with the Health Canada Regions to provide regional coverage for all provinces and territories.
Health Canada thanks all those in the Regional AR Centres who have collaborated with the Marketed Health Products Directorate (MHPD) in the ongoing collection of safety and effectiveness information on marketed health products. The CADRMP is administered by the MHPD, which is responsible for coordination of consistency of post-market surveillance and assessment of signals and safety trends concerning all marketed health products. The CADRMP is responsible for the collection and assessment of adverse reactions that have been submitted by health care professionals or consumers, either directly or through market authorization holders. In Canada, Health Canada has had a system to gather information on adverse reaction reports since 1965. This information is available in French in pdf format. The regional AR monitoring offices work collaboratively with MHPD’s National AR Centre to collect reports submitted by health professionals and consumers (market authorization holders send reports directly to the National AR Centre). Each office has regional responsibility for collection of adverse reaction reports, which are then reviewed for completeness before being forwarded to the National AR Centre for further analysis. The regional AR monitoring offices also:
increase health professional and consumer awareness of, and paticipation in CADRMP;
improve communication between the adverse reaction program and individuals who report adverse reactions;
provide guidance with respect to adverse reaction reporting in order to maximize the quality of reports; and
direct Canadians to Health Canada sources of new safety information regarding Canadian marketed health products. How do you report an adverse reaction? The reporting mechanism remains the same. Toll-free phone and fax lines will be re-routed to the new location and mail will be redirected to the new office. To report an adverse reaction, request a copy of the adverse reaction reporting form or to obtain information about the program, health professionals and consumers may use our toll-free phone or fax lines: Tel: 1-866-234-2345 Fax: 1-866-678-6789 Calls will automatically be routed to the appropriate regional AR monitoring office, based on area code of the caller. Adverse reaction reports can also be mailed to the regional AR monitoring office at the addresses listed below. Where are the Regional Adverse Reaction Monitoring Offices located?
Canadian Adverse Reaction Monitoring - BC and Yukon
400 - 4595 Canada Way,
Burnaby, BC V5G 1J9
British_Columbia_AR@hc-sc.gc.ca
Canadian Adverse Reaction Monitoring - Alberta and Northwest Territories
Suite 730, 9700 Jasper Avenue
Edmonton, Alberta T5J 4C3
Alberta_AR@hc-sc.gc.ca
Canadian Adverse Reaction Monitoring - Saskatchewan
4th floor, Room 412
101 - 22nd Street East Saskatoon, Saskatchewan S7K 0E1
Saskatchewan_AR@hc-sc.gc.ca
Canadian Adverse Reaction Monitoring - Manitoba
510 LagimodiPre Blv | 
